Patient-Derived Xenografts (PDXs). entailing implantation of cancer specimens in immunocompromised mice. are emerging as a valuable translational model that could help validate biologically relevant targets and assist the clinical development of novel therapeutic strategies for gastric cancer. More than 30% of PDXs generated from gastric carcinoma samples developed human B-cell lympho... https://www.markbroyard.com/